Fourth BNT162b2 COVID-19 Vaccine Dose

Clinical trial NCT05231005 · UNKNOWN

Trial details

NCT number: NCT05231005
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2021-12-27
Primary completion: 2024-06-26
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.